Log in

Fulgent Genetics Stock Price, News & Analysis (NASDAQ:FLGT)

$11.51
+0.14 (+1.23 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$11.17
Now: $11.51
$11.62
50-Day Range
$9.94
MA: $11.27
$12.09
52-Week Range
$3.02
Now: $11.51
$12.88
Volume66,980 shs
Average Volume98,006 shs
Market Capitalization$212.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.96
Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.36 million
Book Value$2.83 per share

Profitability

Net Income$-5,610,000.00

Miscellaneous

Employees123
Market Cap$212.82 million
Next Earnings Date11/4/2019 (Confirmed)
OptionableNot Optionable

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.


Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) posted its quarterly earnings results on Monday, August, 5th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.06. The business had revenue of $8.42 million for the quarter, compared to the consensus estimate of $6.42 million. Fulgent Genetics had a negative return on equity of 4.71% and a negative net margin of 12.38%. View Fulgent Genetics' Earnings History.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Fulgent Genetics.

How can I listen to Fulgent Genetics' earnings call?

Fulgent Genetics will be holding an earnings conference call on Monday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for FLGT?

2 brokerages have issued 1-year price objectives for Fulgent Genetics' shares. Their predictions range from $9.50 to $9.50. On average, they anticipate Fulgent Genetics' stock price to reach $9.50 in the next year. This suggests that the stock has a possible downside of 17.5%. View Analyst Price Targets for Fulgent Genetics.

What is the consensus analysts' recommendation for Fulgent Genetics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Fulgent Genetics.

Has Fulgent Genetics been receiving favorable news coverage?

Media stories about FLGT stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fulgent Genetics earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Fulgent Genetics.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a decrease in short interest during the month of September. As of September 15th, there was short interest totalling 102,400 shares, a decrease of 5.2% from the August 15th total of 108,000 shares. Based on an average trading volume of 70,100 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.6% of the company's shares are short sold. View Fulgent Genetics' Current Options Chain.

Who are some of Fulgent Genetics' key competitors?

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include Crispr Therapeutics (CRSP), Zynerba Pharmaceuticals (ZYNE), Baidu (BIDU), Baozun (BZUN), Catalyst Pharmaceuticals (CPRX), Intellia Therapeutics (NTLA), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), DexCom (DXCM) and Fate Therapeutics (FATE).

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 63)
  • Mr. Paul Kim, Chief Financial Officer (Age 52)
  • Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 52)

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $11.51.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $212.82 million and generates $21.36 million in revenue each year. The company earns $-5,610,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Fulgent Genetics employs 123 workers across the globe.View Additional Information About Fulgent Genetics.

What is Fulgent Genetics' official website?

The official website for Fulgent Genetics is http://www.fulgentgenetics.com/.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE SUITE 205, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (NASDAQ FLGT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  202 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Hold Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel